|
Neoplasia
Citations 221-230 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
- Alessandra Ferrajoli, Bang-Ning Lee, Ellen J. Schlette, Susan M. O'Brien, Hui Gao, Sijin Wen, William G. Wierda, Zeev Estrov, Stefan Faderl, Evan N. Cohen, Changping Li, James M. Reuben, and Michael J. Keating
Blood 2008; 111: 5291-5297.
[Abstract]
[Full text]
[PDF]
Development and dynamics of robust T-cell responses to CML under imatinib treatment
- Christiane I-U. Chen, Holden T. Maecker, and Peter P. Lee
Blood 2008; 111: 5342-5349.
[Abstract]
[Full text]
[PDF]
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma
- Luca Paoluzzi, Mithat Gonen, Jeffrey R. Gardner, Jill Mastrella, Dajun Yang, Jon Holmlund, Mel Sorensen, Lance Leopold, Katia Manova, Guido Marcucci, Mark L. Heaney, and Owen A. O'Connor
Blood 2008; 111: 5350-5358.
[Abstract]
[Full text]
[PDF]
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
- Sajjan Mittal, Neil A. Marshall, Linda Duncan, Dominic J. Culligan, Robert N. Barker, and Mark A. Vickers
Blood 2008; 111: 5359-5370.
[Abstract]
[Full text]
[PDF]
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study
- Christian Langer, Michael D. Radmacher, Amy S. Ruppert, Susan P. Whitman, Peter Paschka, Krzysztof Mrózek, Claudia D. Baldus, Tamara Vukosavljevic, Chang-Gong Liu, Mary E. Ross, Bayard L. Powell, Albert de la Chapelle, Jonathan E. Kolitz, Richard A. Larson, Guido Marcucci, and Clara D. Bloomfield
Blood 2008; 111: 5371-5379.
[Abstract]
[Full text]
[PDF]
Myelodysplastic syndromes
- Stephen D. Nimer
Blood 2008; 111: 4841-4851.
[Abstract]
[Full text]
[PDF]
Appraisal of immunoglobulin free light chain as a marker of response
- Angela Dispenzieri, Lijun Zhang, Jerry A. Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kimberly Henderson, Robert A. Kyle, Martin M. Oken, Arthur R. Bradwell, and Philip R. Greipp
Blood 2008; 111: 4908-4915.
[Abstract]
[Full text]
[PDF]
Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century
- Hermann Brenner, Adam Gondos, and Dianne Pulte
Blood 2008; 111: 4916-4921.
[Abstract]
[Full text]
[PDF]
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- Jean-Jacques Kiladjian, Francisco Cervantes, Franck W. G. Leebeek, Christophe Marzac, Bruno Cassinat, Sylvie Chevret, Dominique Cazals-Hatem, Aurélie Plessier, Juan-Carlos Garcia-Pagan, Sarwa Darwish Murad, Sebastian Raffa, Harry L. A. Janssen, Claude Gardin, Sophie Cereja, Carole Tonetti, Stéphane Giraudier, Bertrand Condat, Nicole Casadevall, Pierre Fenaux, and Dominique C. Valla
Blood 2008; 111: 4922-4929.
[Abstract]
[Full text]
[PDF]
Structural and numerical variation of FLT3/ITD in pediatric AML
- Soheil Meshinchi, Derek L. Stirewalt, Todd A. Alonzo, Titus J. Boggon, Robert B. Gerbing, Jennifer L. Rocnik, Beverly J. Lange, D. Gary Gilliland, and Jerald P. Radich
Blood 2008; 111: 4930-4933.
[Abstract]
[Full text]
[PDF]
|
|
